Yipinhong Pharmaceutical Co Ltd Class A (300723) - Total Assets
Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) holds total assets worth CN¥4.53 Billion CNY (≈ $663.19 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Yipinhong Pharmaceutical Co Ltd Class A for net asset value and shareholders' equity analysis.
Yipinhong Pharmaceutical Co Ltd Class A - Total Assets Trend (2013–2024)
This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's total assets have evolved over time, based on quarterly financial data.
Yipinhong Pharmaceutical Co Ltd Class A - Asset Composition Analysis
Current Asset Composition (December 2024)
Yipinhong Pharmaceutical Co Ltd Class A's total assets of CN¥4.53 Billion consist of 28.6% current assets and 71.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.7% |
| Accounts Receivable | CN¥362.34 Million | 8.2% |
| Inventory | CN¥287.13 Million | 6.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥441.17 Million | 10.0% |
| Goodwill | CN¥255.94K | 0.0% |
Asset Composition Trend (2013–2024)
This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Yipinhong Pharmaceutical Co Ltd Class A.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yipinhong Pharmaceutical Co Ltd Class A's current assets represent 28.6% of total assets in 2024, a decrease from 37.4% in 2013.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2024, up from 7.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 22.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 10.0% of total assets.
Yipinhong Pharmaceutical Co Ltd Class A Competitors by Total Assets
Key competitors of Yipinhong Pharmaceutical Co Ltd Class A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535
|
China | CN¥15.34 Billion |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
|
China | CN¥15.32 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
Yipinhong Pharmaceutical Co Ltd Class A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.49 | 1.05 | 2.17 |
| Quick Ratio | 1.22 | 0.86 | 1.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥507.12 Million | CN¥70.04 Million | CN¥652.22 Million |
Yipinhong Pharmaceutical Co Ltd Class A - Advanced Valuation Insights
This section examines the relationship between Yipinhong Pharmaceutical Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.26 |
| Latest Market Cap to Assets Ratio | 0.62 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | CN¥4.40 Billion |
| Market Capitalization | $2.74 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Yipinhong Pharmaceutical Co Ltd Class A's assets below their book value (0.62x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Yipinhong Pharmaceutical Co Ltd Class A's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Yipinhong Pharmaceutical Co Ltd Class A (2013–2024)
The table below shows the annual total assets of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.40 Billion ≈ $644.46 Million |
-0.03% |
| 2023-12-31 | CN¥4.41 Billion ≈ $644.63 Million |
+7.49% |
| 2022-12-31 | CN¥4.10 Billion ≈ $599.73 Million |
+10.64% |
| 2021-12-31 | CN¥3.70 Billion ≈ $542.07 Million |
+72.69% |
| 2020-12-31 | CN¥2.15 Billion ≈ $313.90 Million |
+19.52% |
| 2019-12-31 | CN¥1.79 Billion ≈ $262.64 Million |
+0.78% |
| 2018-12-31 | CN¥1.78 Billion ≈ $260.61 Million |
+20.18% |
| 2017-12-31 | CN¥1.48 Billion ≈ $216.85 Million |
+96.98% |
| 2016-12-31 | CN¥752.32 Million ≈ $110.09 Million |
+19.31% |
| 2015-12-31 | CN¥630.56 Million ≈ $92.27 Million |
-14.07% |
| 2014-12-31 | CN¥733.80 Million ≈ $107.38 Million |
+78.42% |
| 2013-12-31 | CN¥411.27 Million ≈ $60.18 Million |
-- |
About Yipinhong Pharmaceutical Co Ltd Class A
ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao'er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxia… Read more